Keith Murphy

Organovo, a biotechnology company focused on "changing the shape of medical research and practice," has made leaps and bound in the area of 3D printing and biotech through bioprinting human tissue. According to the company, "At Organovo, we design and create functional human tissues using our...

“I think people are missing the forest for the trees,” Organovo Holdings Inc (NYSE: ONVO) CEO Keith Murphy told Benzinga. Murphy’s remarks were in reference to Cantor Fitzgerald’s downgrade of Organovo from Buy to Hold following the company’s reported $8.5 million...

“We may not have communicated well enough to investors about what to expect,” said Organovo Holdings (NYSE: ONVO) CEO Keith Murphy in an exclusive interview with Benzinga. Murphy outlined two factors that, in his view, may have contributed to impatience on the part of investors....

3D printing has found its way into a number of industries, including health care and medical technology. Organovo Holdings Inc (NYSE: ONVO), in particular, is one of the companies researching how 3D-printed technology can be useful in medical fields. The company focuses on the design and...